I am running The United Airlines NYC half marathon in March to support ALS United Greater NY in honor of my father-in-law, Allen. He has been navigating Primary Lateral Sclerosis (PLS), a rare neurodegenerative motor neuron disorder related to ALS, which brings challenges with movement and mobility. I’m setting a fundraising goal of $2,500 to fuel research, vital care services, and advocacy for people living with ALS and related disorders and their families. 

Access to multidisciplinary care, assistive technology, counseling, and caregiver support can make a meaningful difference in quality of life. Your support today helps make that possible.

Please join me: donate, share, and help me cross both the finish line and my fundraising goal for a community that needs our support now.

More information about ALS and ALS United Greater New York can be found below. 

Amyotrophic lateral sclerosis (ALS), often referred to as "Lou Gehrig's Disease," is a progressive disease of the nervous system that affects cells in the brain and spinal cord. Presently, there is no known cure for ALS.

• Every ninety minutes, someone is diagnosed with the disease, and someone passes away from it.
• 90% of ALS cases occur without any known family history or genetic cause. The remaining 10% of ALS cases are inherited through a mutated gene with a known connection to the disease.
• 55 is the average age of onset with most people who develop ALS between the ages of 40 and 70. However, cases of the disease do occur in people in their twenties and thirties.
• ALS is 20% more common in men than women. However, with increasing age, the incidence of ALS is more equal between men and women.
• Military veterans are twice as likely to be diagnosed with the disease than the general public for yet unknown reasons.